Competitive Landscape by Indication
151 indications, 101,562 trials mapped
Oncology
39,733 trialsSolid Tumor (Advanced)
6371 trials
534 Ph3
Merck, Sichuan Baili Pharmaceutical Co., Ltd., Eli Lilly
Breast Cancer
2529 trials
441 Ph3
AstraZeneca, Roche, Pfizer
Non-Hodgkin Lymphoma
2519 trials
221 Ph3
Roche, Genmab, Merck
NSCLC
2438 trials
392 Ph3
AstraZeneca, Merck, Roche
ALL
1934 trials
292 Ph3
Novartis, AstraZeneca, Sichuan Baili Pharmaceutical Co., Ltd.
Colorectal Cancer
1795 trials
244 Ph3
AstraZeneca, AbbVie, Revolution Medicines, Inc.
Prostate Cancer
1607 trials
249 Ph3
Novartis, Johnson & Johnson, AstraZeneca
AML
1255 trials
114 Ph3
AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.
Multiple Myeloma
1197 trials
142 Ph3
Johnson & Johnson, GSK, AbbVie
Pancreatic Cancer
1116 trials
103 Ph3
AstraZeneca, Revolution Medicines, Inc., Seagen, a wholly owned subsidiary of Pfizer
Melanoma
1078 trials
99 Ph3
Merck, Pfizer, Novartis
Hepatocellular Carcinoma
999 trials
142 Ph3
AstraZeneca, Roche, Akeso
Hematologic Malignancies
989 trials
86 Ph3
Johnson & Johnson, Novartis, Orca Biosystems, Inc.
Ovarian Cancer
975 trials
116 Ph3
AstraZeneca, AbbVie, Merck
Head and Neck Cancer
939 trials
77 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Pfizer
Lung Cancer (General)
919 trials
120 Ph3
Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.
Sarcoma
892 trials
62 Ph3
Eli Lilly, Hansoh BioMedical R&D Company, Philogen S.p.A.
Bladder Cancer
821 trials
121 Ph3
Merck, AstraZeneca, Pfizer
Gastric Cancer
805 trials
120 Ph3
AstraZeneca, Astellas Pharma Global Development, Inc., Chongqing Precision Biotech Co., Ltd
MDS
715 trials
58 Ph3
Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.
Esophageal Cancer
704 trials
114 Ph3
AstraZeneca, Merck, AbbVie
Glioblastoma
628 trials
43 Ph3
Novartis, Philogen S.p.A., GT Medical Technologies, Inc.
Brain Tumor
618 trials
51 Ph3
Jazz Pharmaceuticals, Pfizer, InSightec
Renal Cell Carcinoma
544 trials
50 Ph3
Merck, Bristol-Myers Squibb, Exelixis
SCLC
543 trials
74 Ph3
Amgen, AstraZeneca, Merck
Triple Negative Breast Cancer
517 trials
55 Ph3
Gilead, Novartis, Eli Lilly
Squamous Cell Carcinoma
495 trials
48 Ph3
Regeneron, Merck, Alentis Therapeutics AG
Hodgkin Lymphoma
491 trials
31 Ph3
Merck, AbbVie, Sichuan Baili Pharmaceutical Co., Ltd.
Cholangiocarcinoma
468 trials
45 Ph3
AstraZeneca, Eli Lilly, TransThera Sciences (Nanjing), Inc.
Cervical Cancer
439 trials
72 Ph3
AstraZeneca, Shanghai Bovax Biotechnology Co., Ltd., Merck
CLL
432 trials
49 Ph3
BeOne Medicines, AbbVie, Acerta Pharma BV
Neuroendocrine Tumors
403 trials
79 Ph3
Vertex Pharmaceuticals Incorporated, Crinetics Pharmaceuticals Inc., ITM Solucin GmbH
Endometrial Cancer
366 trials
43 Ph3
AstraZeneca, Merck, Genmab
Myelofibrosis
228 trials
30 Ph3
Novartis, Bristol-Myers Squibb, Incyte Corporation
Mesothelioma
218 trials
14 Ph3
Novartis, NGM Biopharmaceuticals, Inc, Seagen, a wholly owned subsidiary of Pfizer
CML
204 trials
18 Ph3
Novartis, Shenzhen TargetRx, Inc., Jiangsu Hansoh Pharmaceutical Co., Ltd.
Thyroid Cancer
166 trials
25 Ph3
Eli Lilly, Exelixis, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
HER2+ Breast Cancer
148 trials
31 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., Shanghai JMT-Bio Inc., Roche
HER2- Breast Cancer
139 trials
15 Ph3
AstraZeneca, BeiGene, Olema Pharmaceuticals, Inc.
Merkel Cell Carcinoma
89 trials
6 Ph3
TuHURA Biosciences, Inc., ImmunityBio, Inc., Neonc Technologies, Inc.
Immunology
20,592 trialsRheumatoid Arthritis
9032 trials
2069 Ph3
AstraZeneca, Novartis, AbbVie
Ankylosing Spondylitis
7558 trials
1650 Ph3
Eli Lilly, AstraZeneca, Novartis
Ulcerative Colitis
1251 trials
270 Ph3
Takeda, AbbVie, Eli Lilly
Lupus
854 trials
154 Ph3
Novartis, AstraZeneca, Bristol-Myers Squibb
Psoriasis
648 trials
217 Ph3
Johnson & Johnson, Bristol-Myers Squibb, UCB Biopharma SRL
Atopic Dermatitis
633 trials
174 Ph3
Pfizer, AbbVie, Keymed Biosciences Co.Ltd
Crohn's Disease
333 trials
98 Ph3
Takeda, Johnson & Johnson, AbbVie
Psoriatic Arthritis
142 trials
56 Ph3
UCB Biopharma SRL, AbbVie, Eli Lilly
IBD
141 trials
20 Ph3
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company), Eli Lilly, Spyre Therapeutics, Inc.
Cardiovascular
8,558 trialsMyocardial Infarction
4196 trials
995 Ph3
AstraZeneca, Novartis, Bristol-Myers Squibb
Atrial Fibrillation
1085 trials
214 Ph3
Incyte Corporation, Novartis, Sanofi
Hypertension
1045 trials
297 Ph3
Boryung Pharmaceutical Co., Ltd, Addpharma Inc., Merck
Stroke
745 trials
269 Ph3
Tisento Therapeutics, Beijing Suncadia Pharmaceuticals Co., Ltd, Shin Poong Pharmaceutical Co. Ltd.
Heart Failure
739 trials
159 Ph3
Novo Nordisk, AstraZeneca, Tasly Pharmaceutical Group Co., Ltd
Coronary Artery Disease
474 trials
88 Ph3
Novartis, XyloCor Therapeutics, Inc., Sinotau Pharmaceutical Group
Thrombosis
167 trials
66 Ph3
Regeneron, Boston Scientific Corporation, Anthos Therapeutics, Inc.
Arrhythmia
60 trials
18 Ph3
Cardurion Pharmaceuticals, Inc., Solid Biosciences Inc., Agiana Pharmaceuticals
Hypertrophic Cardiomyopathy
47 trials
16 Ph3
Shandong Suncadia Medicine Co., Ltd., Cytokinetics, Bristol-Myers Squibb
CNS
6,651 trialsMajor Depression
1007 trials
245 Ph3
Neurocrine Biosciences, Johnson & Johnson, Neumora Therapeutics, Inc.
Alzheimer's Disease
966 trials
188 Ph3
Eli Lilly, Bristol-Myers Squibb, Roche
Multiple Sclerosis
767 trials
188 Ph3
Roche, Novartis, Sanofi
Parkinson's Disease
559 trials
80 Ph3
iRegene Therapeutics Co., Ltd., Luye Pharma Group Ltd., Roche
Schizophrenia
426 trials
117 Ph3
Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb
Opioid Use Disorder
365 trials
73 Ph3
Indivior Inc., Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC
ALS
354 trials
79 Ph3
Amylyx Pharmaceuticals Inc., Biogen, XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Migraine
346 trials
156 Ph3
AbbVie, Pfizer, H. Lundbeck A/S
Epilepsy
294 trials
88 Ph3
UCB Biopharma SRL, Xenon Pharmaceuticals Inc., SK Life Science, Inc.
Alcohol Use Disorder
277 trials
42 Ph3
Eli Lilly, Afasci Inc, Pop Test Oncology LLC
Anxiety
259 trials
51 Ph3
VistaGen Therapeutics, Inc., Definium Therapeutics US, Inc., Intra-Cellular Therapies, Inc.
Neuropathy
237 trials
64 Ph3
argenx, Sanofi, Takeda
Autism Spectrum Disorder
215 trials
44 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, MapLight Therapeutics
PTSD
183 trials
37 Ph3
Oui Therapeutics, Inc., Senseye, Inc., Otsuka Medical Devices Co., Ltd. Japan
ADHD
161 trials
65 Ph3
Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc., Boehringer Ingelheim
Bipolar Disorder
130 trials
40 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Xenon Pharmaceuticals Inc.
Huntington's Disease
54 trials
9 Ph3
Roche, Novartis, Skyhawk Therapeutics, Inc.
OCD
51 trials
6 Ph3
Vericel Corporation, Biohaven Pharmaceuticals, Inc.
Infectious Disease
6,525 trialsCOVID-19
2231 trials
739 Ph3
BioNTech SE, ModernaTX, Inc., Novavax
HIV
1192 trials
222 Ph3
ViiV Healthcare, Gilead, Merck
Influenza
701 trials
172 Ph3
GSK, Sanofi, Valenta Pharm JSC
Hepatitis B
389 trials
43 Ph3
GSK, Ausper Biopharma Co., Ltd., Beijing Continent Pharmaceutical Co, Ltd.
Malaria
336 trials
64 Ph3
Sanaria Inc., GSK, Novartis
Sepsis
327 trials
102 Ph3
Bayer, Tianjin Chasesun Pharmaceutical Co., LTD, Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Hepatitis C
324 trials
107 Ph3
Atea Pharmaceuticals, Inc., Gilead, AbbVie
Tuberculosis
294 trials
81 Ph3
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Shanghai Jiatan Pharmatech Co., Ltd, Otsuka Pharmaceutical Development & Commercialization, Inc.
RSV
245 trials
65 Ph3
GSK, ModernaTX, Inc., Sanofi
H. pylori
157 trials
33 Ph3
ARJ Medical, Inc., Catalysis SL, TenNor Therapeutics (Suzhou) Limited
Fungal Infections
123 trials
33 Ph3
Mundipharma Research Limited, F2G Biotech GmbH, Basilea Pharmaceutica
C. difficile
108 trials
28 Ph3
Vedanta Biosciences, Inc., AstraZeneca, Theriva Biologics, Inc.
Bacterial Infections
98 trials
16 Ph3
Pfizer, Qpex Biopharma, Inc., CanSino Biologics Inc.
Metabolic
5,032 trialsType 2 Diabetes
1320 trials
373 Ph3
Eli Lilly, Novo Nordisk, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Obesity
1124 trials
259 Ph3
Eli Lilly, Novo Nordisk, Amgen
Diabetes (General)
826 trials
187 Ph3
Gan & Lee Pharmaceuticals., Eli Lilly, EMS
NASH/NAFLD
487 trials
55 Ph3
GSK, Akero Therapeutics, Inc, Madrigal Pharmaceuticals, Inc.
Type 1 Diabetes
463 trials
95 Ph3
Eli Lilly, Sanofi, Novo Nordisk
Dyslipidemia
447 trials
166 Ph3
Addpharma Inc., Novartis, Qilu Pharmaceutical Co., Ltd.
Diabetic Complications
365 trials
82 Ph3
Roche, EyeBiotech Ltd., Novartis
Pain
2,723 trialsAcute Pain
1595 trials
418 Ph3
Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Eli Lilly, AFT Pharmaceuticals, Ltd.
Postoperative Pain
759 trials
160 Ph3
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., Pacira Pharmaceuticals, Inc, Haisco Pharmaceutical Group Co., Ltd.
Chronic Pain
186 trials
43 Ph3
Evon Medics LLC, iN Therapeutics Co., Ltd., Sustained Therapeutics Inc.
Neuropathic Pain
183 trials
33 Ph3
Vertex Pharmaceuticals Incorporated, Eli Lilly, Haisco Pharmaceutical Group Co., Ltd.
Respiratory
2,384 trialsAsthma
697 trials
206 Ph3
AstraZeneca, GSK, Sanofi
COPD
536 trials
122 Ph3
AstraZeneca, GSK, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Pneumonia
484 trials
154 Ph3
GSK, Avidity Biosciences, Inc., Qilu Pharmaceutical Co., Ltd.
Cystic Fibrosis
304 trials
80 Ph3
Vertex Pharmaceuticals Incorporated, Sionna Therapeutics Inc., Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
222 trials
36 Ph3
Boehringer Ingelheim, Bristol-Myers Squibb, Guangdong Hengrui Pharmaceutical Co., Ltd
Allergic Rhinitis
141 trials
53 Ph3
Genrix (Shanghai) Biopharmaceutical Co., Ltd., Prime Gene Therapeutics Co., Ltd., ALK-Abelló A/S
Urology
2,367 trialsErectile Dysfunction
2117 trials
498 Ph3
AstraZeneca, Novartis, Nanjing Leads Biolabs Co.,Ltd
Overactive Bladder
182 trials
44 Ph3
Levee Medical, Inc., Cook MyoSite, TBF Genie Tissulaire
Benign Prostatic Hyperplasia
68 trials
20 Ph3
Addpharma Inc., Resurge Therapeutics Inc., Chong Kun Dang Pharmaceutical
Musculoskeletal
1,308 trialsOsteoarthritis
923 trials
244 Ph3
Eli Lilly, Pacira Pharmaceuticals, Inc, UCB Biopharma SRL
Osteoporosis
192 trials
48 Ph3
Amgen, Qilu Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd.
Gout
153 trials
28 Ph3
Arthrosi Therapeutics, Jiangsu HengRui Medicine Co., Ltd., Atom Therapeutics Co., Ltd
Muscle Spasm
40 trials
12 Ph3
RVL Pharmaceuticals, Inc., Ipsen, Merz Pharmaceuticals GmbH
Rare Disease
1,245 trialsSpinal Muscular Atrophy
334 trials
84 Ph3
Roche, Wuhan Createrna Science and Technology Co., Ltd, Novartis
Sickle Cell Disease
254 trials
56 Ph3
Novartis, Vertex Pharmaceuticals Incorporated, Novo Nordisk
Immune Thrombocytopenia
253 trials
79 Ph3
Novartis, Jiangsu HengRui Medicine Co., Ltd., argenx
Hemophilia
198 trials
78 Ph3
Pfizer, Roche, CSL Behring
Duchenne Muscular Dystrophy
114 trials
25 Ph3
NS Pharma, Inc., Italfarmaco, Solid Biosciences Inc.
Fabry Disease
39 trials
21 Ph3
Chiesi Farmaceutici S.p.A., Amicus Therapeutics, Sanofi
Gaucher Disease
28 trials
5 Ph3
Spur Therapeutics, Prevail Therapeutics, Genzyme, a Sanofi Company
Mastocytosis
20 trials
2 Ph3
Blueprint Medicines Corporation, Cogent Biosciences, Inc., MacroGenics
CDKL5 Deficiency Disorder
5 trials
3 Ph3
Zogenix, Inc., Immedica Pharma AB, Marinus Pharmaceuticals
Ophthalmology
906 trialsGastrointestinal
877 trialsPeptic Ulcer
334 trials
82 Ph3
Johnson & Johnson, Sanofi, Cellution Biologics
Nausea/Vomiting
222 trials
67 Ph3
Helsinn Healthcare SA, Vanda Pharmaceuticals, Eli Lilly
Constipation
130 trials
40 Ph3
Ardelyx, Shionogi, HK inno.N Corporation
Diarrhea
124 trials
27 Ph3
Crinetics Pharmaceuticals Inc., Tasly Pharmaceutical Group Co., Ltd, Vedanta Biosciences, Inc.
GERD
67 trials
14 Ph3
Cinclus Pharma Holding AB, Takeda, Addpharma Inc.
Renal
783 trialsWomen's Health
652 trialsInfertility
253 trials
86 Ph3
IBSA Institut Biochimique SA, Qilu Pharmaceutical Co., Ltd., Fertility Center of Las Vegas
Menopause
130 trials
32 Ph3
Astellas Pharma Global Development, Inc., Bayer, Astellas Pharma Inc
PCOS
127 trials
37 Ph3
Wellizen Australia, Fujian Shengdi Pharmaceutical Co., Ltd., PT. Prodia Stem Cell Indonesia
Endometriosis
111 trials
32 Ph3
Kissei Pharmaceutical Co., Ltd., AbbVie, Hope Medicine (Nanjing) Co., Ltd
Contraception
31 trials
8 Ph3
YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences
Dermatology
578 trialsAcne
226 trials
72 Ph3
Sanofi, AbbVie, Galderma R&D
Alopecia
191 trials
50 Ph3
Pfizer, Applied Biology, Inc., Veradermics, Inc.
Vitiligo
77 trials
19 Ph3
Incyte Corporation, Pfizer, Jiangsu HengRui Medicine Co., Ltd.
Rosacea
70 trials
20 Ph3
Tarsus Pharmaceuticals, Inc., Sol-Gel Technologies, Ltd., Vyne Therapeutics Inc.
Skin Infections
14 trials
3 Ph3
AbbVie, UNION therapeutics
Hepatology
274 trialsSleep
233 trialsEndocrine
141 trialsGrowth Hormone Deficiency
53 trials
25 Ph3
Changchun GeneScience Pharmaceutical Co., Ltd., Lumos Pharma, Novo Nordisk
Hypothyroidism
27 trials
8 Ph3
AbbVie, IBSA Institut Biochimique SA, Neuvosyn Laboratories, LLC
Acromegaly
26 trials
8 Ph3
Crinetics Pharmaceuticals Inc., Debiopharm International SA, AstraZeneca
Hyperthyroidism
19 trials
4 Ph3
Merida Biosciences, Biohaven Therapeutics Ltd., Changchun GeneScience Pharmaceutical Co., Ltd.
Adrenal Insufficiency
16 trials
3 Ph3
Neurocrine UK Limited
Click any indication to see full competitive landscape (all sponsors, trials, phases).
Data: ClinicalTrials.gov | Mapping: Indication Taxonomy